SEC Company Response from Zomedica Corp. (ZOM) (CIK 0001684144) (ZOMDF) — Oct 22, 2020
Zomedica Corp. (ZOM) (CIK 0001684144)
Date: Oct. 22, 2020 · CIK: 0001684144 · Accession: 0001171843-20-007183
AI Filing Summary & Sentiment
Letter
Zomedica Corp.
100 Phoenix Drive, Suite 180
Ann Arbor, Michigan 48108
October 22, 2020
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Zomedica Corp. (the “Company”)
Registration Statement on Form S-4 (File No. 333- 249401)
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 9:00 a.m., Eastern Time, on October 26, 2020, or as soon as practicable thereafter.
Please call John D. Hogoboom of Lowenstein Sandler LLP at (973) 597-2382 to confirm the effectiveness of the Registration Statement or with any questions.
[Signature page follows.]
U.S. Securities and Exchange Commission
October 22, 2020
Page 2
Very truly yours,
ZOMEDICA CORP.
Show Raw Text
CORRESP 1 filename1.htm Zomedica Corp. 100 Phoenix Drive, Suite 180 Ann Arbor, Michigan 48108 October 22, 2020 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: Zomedica Corp. (the “Company”) Registration Statement on Form S-4 (File No. 333- 249401) Ladies and Gentlemen: In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 9:00 a.m., Eastern Time, on October 26, 2020, or as soon as practicable thereafter. Please call John D. Hogoboom of Lowenstein Sandler LLP at (973) 597-2382 to confirm the effectiveness of the Registration Statement or with any questions. [Signature page follows.] U.S. Securities and Exchange Commission October 22, 2020 Page 2 Very truly yours, ZOMEDICA CORP. By: /s/ Ann Marie Cotter Name: Ann Marie Cotter Title: Chief Financial Officer -2-